Nifty

:

17196.70

Sensex

:

57696.46

-204.95 (-1.18%)
-764.83 (-1.31%)

Login

Nifty
Sensex

:
:

17196.70
57696.46

-204.95 (-1.18%)
-764.83 (-1.31%)

RPG Life Sciences Ltd.

Pharmaceuticals & Drugs - Global

Rating :

64/99

BSE: 532983 | NSE: RPGLIFE

Watchlist

NSE BSE

603.70

03-Dec-2021

Open
High
Low
Previous Close

606.00
626.55
601.50
609.20

Volume
Traded Value (lacs)
52 Week High
52 Week Low

43101
263.77
752.45
341.90

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

998.05
20.32
8

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

959.32
1.19%
4.27

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

7.27
5.79
5.63

EBITDA CAGR (%)

10 Years
5 Years
3 Years

14.58
19.84
15.50

PAT CAGR (%)

10 Years
5 Years
3 Years

46.98
13.74
54.67

P:E (Median)

8 Years
5 Years
3 Years

26.42
27.96
19.57

P:BV (Average)

8 Years
5 Years
3 Years

3.28
3.28
3.28

EV:EBITDA (Average)

8 Years
5 Years
3 Years

41.91
15.06
10.40

Quarterly Results

Standalone Figures in Rs. Crores /

Consolidated

Description Sep 21 Sep 20 Var% Jun 21 Jun 20 Var% Mar 21 Mar 20 Var% Dec 20 Dec 19 Var%
Net Sales 112.65 97.13 15.98% 108.13 91.65 17.98% 92.76 88.67 4.61% 107.60 94.37 14.02%
Expenses 86.85 78.01 11.33% 85.18 74.80 13.88% 80.10 76.17 5.16% 86.30 79.48 8.58%
EBITDA 25.80 19.12 34.94% 22.95 16.85 36.20% 12.66 12.50 1.28% 21.30 14.89 43.05%
EBIDTM 22.90% 19.68% 21.22% 18.39% 13.65% 14.10% 19.80% 15.78%
Other Income 0.71 0.04 1,675.00% 0.41 0.45 -8.89% 0.30 0.38 -21.05% 0.12 0.04 200.00%
Interest 0.17 0.23 -26.09% 0.13 0.31 -58.06% 0.09 0.30 -70.00% 0.16 0.36 -55.56%
Depreciation 3.99 4.20 -5.00% 3.96 4.16 -4.81% 3.92 4.12 -4.85% 4.19 4.16 0.72%
PBT 22.35 14.73 51.73% 19.27 12.83 50.19% 8.95 3.14 185.03% 17.07 10.41 63.98%
Tax 6.60 3.58 84.36% 5.69 3.77 50.93% 2.03 0.16 1,168.75% 4.20 2.50 68.00%
PAT 15.75 11.15 41.26% 13.58 9.06 49.89% 6.92 2.98 132.21% 12.87 7.91 62.71%
PATM 13.98% 11.48% 12.56% 9.89% 7.46% 3.36% 11.96% 8.38%
EPS 9.55 6.76 41.27% 8.23 5.49 49.91% 4.19 1.81 131.49% 7.80 4.79 62.84%

Description Jun 21 Jun 20 Var% Mar 21 Mar 20 Var% Dec 20 Dec 19 Var% Sep 20 Sep 19 Var%
Net Sales 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Expenses 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBITDA 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBIDTM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Other Income 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Interest 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Depreciation 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PBT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Tax 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PAT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PATM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0

Annual Results

Standalone Figures in Rs. Crores

Right to Left

Description TTM Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12
Net Sales 421.14 389.14 375.57 330.16 343.95 293.64 279.32 242.27 235.55 221.64 192.82 Net Sales Growth 13.26% 3.61% 13.75% -4.01% 17.13% 5.13% 15.29% 2.85% 6.28% 14.95% Cost Of Goods Sold 140.24 121.27 119.63 103.93 106.87 96.02 84.94 77.17 69.44 68.94 48.44 Gross Profit 280.90 267.87 255.94 226.23 237.08 197.62 194.38 165.10 166.11 152.70 144.38 GP Margin 66.70% 68.84% 68.15% 68.52% 68.93% 67.30% 69.59% 68.15% 70.52% 68.90% 74.88% Total Expenditure 338.43 318.37 315.67 295.73 306.89 265.01 257.02 233.76 224.38 206.01 174.67 Power & Fuel Cost - 11.27 11.54 10.38 10.44 9.10 11.23 10.76 10.29 8.76 7.23 % Of Sales - 2.90% 3.07% 3.14% 3.04% 3.10% 4.02% 4.44% 4.37% 3.95% 3.75% Employee Cost - 94.66 90.97 89.93 90.14 75.59 74.13 68.66 62.18 55.20 49.99 % Of Sales - 24.33% 24.22% 27.24% 26.21% 25.74% 26.54% 28.34% 26.40% 24.91% 25.93% Manufacturing Exp. - 23.09 21.85 18.98 21.86 20.63 26.88 23.61 24.59 24.23 21.78 % Of Sales - 5.93% 5.82% 5.75% 6.36% 7.03% 9.62% 9.75% 10.44% 10.93% 11.30% General & Admin Exp. - 28.54 32.76 34.32 35.76 31.57 24.58 21.81 23.67 21.64 20.88 % Of Sales - 7.33% 8.72% 10.39% 10.40% 10.75% 8.80% 9.00% 10.05% 9.76% 10.83% Selling & Distn. Exp. - 22.76 20.13 18.61 22.51 17.90 16.44 11.42 12.19 12.05 11.69 % Of Sales - 5.85% 5.36% 5.64% 6.54% 6.10% 5.89% 4.71% 5.18% 5.44% 6.06% Miscellaneous Exp. - 16.78 18.79 19.58 19.31 14.20 18.82 20.33 22.02 15.19 11.69 % Of Sales - 4.31% 5.00% 5.93% 5.61% 4.84% 6.74% 8.39% 9.35% 6.85% 7.60% EBITDA 82.71 70.77 59.90 34.43 37.06 28.63 22.30 8.51 11.17 15.63 18.15 EBITDA Margin 19.64% 18.19% 15.95% 10.43% 10.77% 9.75% 7.98% 3.51% 4.74% 7.05% 9.41% Other Income 1.54 1.07 0.99 0.80 2.36 9.78 1.96 6.59 2.87 2.25 0.69 Interest 0.55 1.79 2.76 4.86 4.72 3.64 2.49 2.74 2.60 7.47 6.88 Depreciation 16.06 16.47 16.36 15.32 14.34 11.31 10.15 11.36 10.61 9.87 10.22 PBT 67.64 53.58 41.77 15.05 20.36 23.46 11.62 1.00 0.83 0.54 1.74 Tax 18.52 13.58 7.44 4.24 6.91 2.45 0.00 0.00 11.57 -3.87 0.89 Tax Rate 27.38% 25.35% 20.41% 28.17% 33.94% 10.44% 0.00% 0.00% 17.81% -716.67% 51.15% PAT 49.12 40.00 29.01 10.81 13.45 21.01 11.62 1.00 53.40 4.41 0.85 PAT before Minority Interest 49.12 40.00 29.01 10.81 13.45 21.01 11.62 1.00 53.40 4.41 0.85 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 11.66% 10.28% 7.72% 3.27% 3.91% 7.16% 4.16% 0.41% 22.67% 1.99% 0.44% PAT Growth 57.94% 37.88% 168.36% -19.63% -35.98% 80.81% 1,062.00% -98.13% 1,110.88% 418.82% EPS 29.77 24.24 17.58 6.55 8.15 12.73 7.04 0.61 32.36 2.67 0.52

Results Balance Sheet

Standalone Figures in Rs. Crores

Right to Left

Description Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12
Shareholder's Funds 216.45 176.57 160.50 154.75 147.01 133.59 125.16 125.76 76.23 74.14 Share Capital 13.23 13.23 13.23 13.23 13.23 13.23 13.23 13.23 13.23 13.23 Total Reserves 203.22 163.34 147.27 141.52 133.78 120.36 111.93 112.53 63.00 60.91 Non-Current Liabilities 16.19 8.75 9.58 8.37 10.77 22.45 19.93 6.54 22.16 42.35 Secured Loans 0.08 0.22 4.63 10.11 15.89 0.13 0.17 0.30 10.37 16.11 Unsecured Loans 0.66 1.30 1.95 0.12 0.16 0.11 0.15 0.06 0.15 4.56 Long Term Provisions 12.13 8.50 6.19 2.79 2.32 19.60 16.95 1.42 5.55 7.65 Current Liabilities 79.69 82.59 77.82 120.71 78.68 66.80 67.19 76.51 111.67 72.51 Trade Payables 47.44 44.41 25.13 51.87 28.65 33.71 25.30 37.02 47.43 28.87 Other Current Liabilities 18.12 20.30 13.32 18.47 14.91 10.17 6.64 5.19 24.01 16.88 Short Term Borrowings 0.52 5.12 29.04 37.92 24.01 21.96 32.46 13.68 37.09 24.39 Short Term Provisions 13.61 12.76 10.33 12.45 11.11 0.96 2.79 20.62 3.14 2.37 Total Liabilities 312.33 267.91 247.90 283.83 236.46 222.84 212.28 208.81 210.06 189.00 Net Block 113.30 122.89 127.64 130.80 136.67 109.26 104.52 106.05 102.92 108.69 Gross Block 180.44 173.81 162.55 150.65 142.43 189.83 175.51 166.93 153.94 152.15 Accumulated Depreciation 67.14 50.92 34.91 19.85 5.76 80.57 70.99 60.88 51.02 43.46 Non Current Assets 136.48 142.13 150.81 141.21 140.08 135.65 126.18 112.05 110.75 119.63 Capital Work in Progress 11.77 9.98 17.17 8.73 1.82 1.59 0.72 0.84 1.26 1.28 Non Current Investment 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Loans & Adv. 11.41 9.26 6.00 1.68 1.59 24.80 20.94 5.16 6.57 9.66 Other Non Current Assets 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Current Assets 175.85 125.78 97.09 142.62 96.38 87.19 86.10 96.76 99.31 69.37 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 58.33 46.61 41.04 53.69 45.78 39.02 34.48 37.77 29.37 28.79 Sundry Debtors 57.42 63.33 38.90 68.13 39.28 36.99 40.61 36.34 49.29 30.09 Cash & Bank 40.75 1.11 0.77 0.94 1.60 0.80 0.72 0.70 0.78 0.56 Other Current Assets 19.35 8.22 6.93 7.60 9.72 10.38 10.29 21.95 19.87 9.93 Short Term Loans & Adv. 10.64 6.51 9.45 12.26 4.13 9.80 10.29 21.95 11.46 9.93 Net Current Assets 96.16 43.19 19.27 21.91 17.70 20.39 18.91 20.25 -12.36 -3.14 Total Assets 312.33 267.91 247.90 283.83 236.46 222.84 212.28 208.81 210.06 189.00

Cash Flow

Standalone Figures in Rs. Crores

Right to Left

Description Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12
Cash From Operating Activity 58.27 50.17 45.78 14.68 7.33 32.81 -1.97 -5.56 12.32 15.62 PBT 53.58 36.45 15.05 20.36 23.46 11.62 1.00 64.97 0.54 1.74 Adjustment 16.55 22.52 20.08 17.37 6.95 12.64 7.39 -45.77 16.85 16.31 Changes in Working Capital -3.53 -2.37 14.37 -19.35 -18.81 10.92 -6.47 -14.06 -4.68 -0.57 Cash after chg. in Working capital 66.60 56.60 49.50 18.38 11.60 35.18 1.92 5.14 12.71 17.48 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -8.33 -6.43 -3.72 -3.70 -4.27 -2.37 -3.89 -10.70 -0.39 -1.86 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -7.96 -10.70 -19.02 -15.54 -30.06 -15.25 -10.31 59.30 -12.13 -7.83 Net Fixed Assets -8.42 -4.07 -20.34 -15.13 47.17 -15.19 -8.46 -12.57 -1.77 -7.12 Net Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Others 0.46 -6.63 1.32 -0.41 -77.23 -0.06 -1.85 71.87 -10.36 -0.71 Cash from Financing Activity -10.49 -39.30 -26.50 0.11 23.36 -17.58 12.24 -53.65 -0.19 -7.75 Net Cash Inflow / Outflow 39.82 0.17 0.26 -0.75 0.63 -0.02 -0.04 0.09 0.00 0.04 Opening Cash & Equivalents 0.54 0.37 0.11 0.86 0.23 0.25 0.29 0.20 0.20 0.16 Closing Cash & Equivalent 40.36 0.54 0.37 0.11 0.86 0.23 0.25 0.29 0.20 0.20

Financial Ratios

Standalone

Right to Left

Description Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12
Book Value (Rs.) 130.88 106.77 97.05 93.58 88.89 80.78 75.68 76.05 46.10 44.83 ROA 13.79% 11.25% 4.07% 5.17% 9.15% 5.34% 0.47% 25.50% 2.21% 0.44% ROE 20.36% 17.21% 6.86% 8.91% 14.98% 8.98% 0.80% 52.87% 5.87% 1.14% ROCE 27.22% 20.35% 9.81% 12.52% 15.58% 8.97% 2.50% 48.37% 5.99% 6.73% Fixed Asset Turnover 2.20 2.23 2.11 2.37 1.85 1.59 1.47 1.52 1.50 1.34 Receivable days 56.63 49.68 59.16 56.47 45.37 48.80 55.80 63.90 63.14 62.69 Inventory Days 49.22 42.59 52.36 52.29 50.44 46.22 52.39 50.10 46.26 50.47 Payable days 56.17 44.01 56.38 53.51 47.24 47.03 55.90 77.54 78.01 82.51 Cash Conversion Cycle 49.68 48.25 55.15 55.25 48.57 47.99 52.29 36.47 31.38 30.66 Total Debt/Equity 0.01 0.07 0.23 0.35 0.30 0.17 0.27 0.12 0.83 0.73 Interest Cover 30.93 14.21 4.10 5.31 7.45 5.67 1.36 25.99 1.07 1.25

Top Investors:

authum investment and infrastructure limited

Annual Reports:

News Update:

RPG Life Sciences - Quarterly Results
29th Oct 2021, 17:31 PM

Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback